The CYP17 MSP AI (T-34C) and CYP19A1 (Trp39Arg) variants in polycystic ovary syndrome: A case-control study
Authors:
Open Access
- 29 May 2019
- journal article
- research article
- Published by Knowledge E DMCC in International Journal of Reproductive BioMedicine (IJRM)
- Vol. 17 (3) , 201-208
Abstract
Background: Polycystic ovary syndrome (PCOS) is a common and chronic disorder of endocrine glands where genetic factors play a major role in the susceptibility to the disease. The cytochrome (CYP) 17 enzyme is essential for androgens biosynthesis. Also, the CYP19 enzyme converts the androgens to the aromatic estrogens.Objective: We aimed to investigate the association of CYP 17 MSP AI (T-34C) and CYP 19A1 (Trp39Arg) variants with the pathogenesis of PCOS in a population from Western Iran with Kurdish ethnic background.Materials and Methods: The present case-control study consisted of 50 patients with PCOS and 109 controls. The CYP17 T-34C and CYP19A1 (Trp39Arg) polymorphisms were identified by polymerase chain reaction-restriction fragment length polymorphism. The serum lipid and lipoprotein profile were detected by the Bionic Diagnostic Kits. Estradiol, dehydroepiandrosterone (DHEA), and sex hormone-binding globulin (SHBG) levels were measured using the chemiluminescent method.Results: The serum levels of estradiol and SHBG in PCOS patients were lower than controls (p < 0.001 and p =0.06, respectively). However, the level of DHEA was higher (p= 0.01) in patients compared to controls. The higher frequency of CYP17 TC genotype in patients (30%) compared to controls (15.6%) was associated with 2.31-fold susceptibility to PCOS (p = 0.038). The frequency of CYP19 TC genotype was 6.4% in controls and10% in patients (p = 0.42).Conclusion: The present study suggests that CYP17 TC genotype could be associated with the risk of PCOS. Also, the study indicated the sex steroid hormones level alteration and the lower level of SHBG in PCOS patients compared to healthy individuals.Keywords
This publication has 26 references indexed in Scilit:
- Polymorphism T→C of gene CYP17 promoter and polycystic ovary syndrome risk: A meta-analysisGene, 2012
- Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndromeGynecological Endocrinology, 2011
- Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patientsMolecular and Cellular Biochemistry, 2011
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosisNature Reviews Endocrinology, 2011
- CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndromeFertility and Sterility, 2009
- Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndromeJournal of Assisted Reproduction and Genetics, 2009
- Variable Phenotypes Associated with Aromatase (CYP19) Insufficiency in HumansThe Journal of Clinical Endocrinology & Metabolism, 2007
- Investigations on the genetic polymorphism in the region ofCYP17gene encoding 5′-UTR in patients with polycystic ovarian syndromeGynecological Endocrinology, 2001
- Polymorphism T→C (−34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndromeFertility and Sterility, 1999
- Frequency of a polymorphism in the regulatory region of the 17α-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic statesClinical Endocrinology, 1997